Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

By Florian Lordick, C. Mariette, K. Haustermans, R. Obermannova, D. Arnold. Annals of Oncology, 2013

930 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/38b5be0bd1e99b7e88c7fe9cf8d95614054e5351

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. X. D’Journo
2. Yu-ping Chen
3. Hui Liu
4. Yongtao Han
5. J. Xiang
6. Baofu Chen
7. A. Brunelli
8. W. Mao

Citations in the corpus

• Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma. (2022, neutral): “Mucosal inflammation 33 (11) 8 (3) 4 (1) 0 26 (9) 4 (1)”
• Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial (2018, background): “NCRT plus surgery and surgery alone are standard treatments for patients with locally advanced ESCC.(21-23) The CROSS phase III trial indicated that NCRT followed by surgery significantly improved OS in patients with esophageal or esophagogastric junction cancer when compared with surgery alone.”